Research programme: cognitive disorders therapeutics - Targacept/sanofi-aventis
Alternative Names: AVE 3183; TC-1827Latest Information Update: 22 Aug 2005
At a glance
- Originator Targacept
- Class Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders; Parkinson's disease
Most Recent Events
- 30 Jun 2005 Preclinical data from a media release have been added to the Alzheimer's Disease and Cognition Disorders pharmacodynamics section
- 31 Mar 2005 Discontinued - Preclinical for Cognition disorders in USA (PO)
- 22 Nov 2004 A preclinical study has been added to the Alzheimer's Disease and Cognition Disorders pharmacodynamics section